Ignite Creation Date:
2025-12-24 @ 10:31 PM
Ignite Modification Date:
2026-02-13 @ 3:10 AM
Study NCT ID:
NCT01695135
Status:
COMPLETED
Last Update Posted:
2019-07-18
First Post:
2012-09-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08-09
Start Date Type:
ACTUAL
Primary Completion Date:
2014-06-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05-08
Completion Date Type:
ACTUAL
First Submit Date:
2012-09-25
First Submit QC Date:
None
Study First Post Date:
2012-09-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-05-07
Results First Submit QC Date:
None
Results First Post Date:
2019-07-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-07
Last Update Post Date:
2019-07-18
Last Update Post Date Type:
ACTUAL